[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Muurahainen et al., 1993 - Google Patents

Intravenous infusion of bombesin reduces food intake in humans

Muurahainen et al., 1993

Document ID
17233409678995623295
Author
Muurahainen N
Kissileff H
Pi-Sunyer F
Publication year
Publication venue
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

External Links

Snippet

Infusion of bombesin into healthy young men at two dosages (1.33 and 4.0 ng. kg-1. min-1) resulted in a significant 135-g reduction in intake of a yogurt and fruit blend, compared with saline infusions, at the higher dose, but only a 20-g (nonsignificant) reduction at the lower …
Continue reading at journals.physiology.org (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2278Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL

Similar Documents

Publication Publication Date Title
Muurahainen et al. Intravenous infusion of bombesin reduces food intake in humans
Geary et al. Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men
Pi-Sunyer et al. C-terminal octapeptide of cholecystokinin decreases food intake in obese men
US6468962B1 (en) Nutritional intervention composition for enhancing and extending satiety
Gutzwiller et al. Effect of intravenous human gastrin-releasing peptide on food intake in humans
Levine et al. Sugars and fats: the neurobiology of preference
Muurahainen et al. Effect of a soup preload on reduction of food intake by cholecystokinin in humans
TW200812503A (en) Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
CA2260892A1 (en) Appetite suppression
JP2011514323A (en) Systems and methods using therapeutic nutrition for the management of age-related and age-specific health status of the elderly
Hosobuchi et al. Tryptophan loading may reverse tolerance to opiate analgesics in humans: a preliminary report
US20210360958A1 (en) Sleep-improving compositions
EP2397039A1 (en) Compositions for delaying progression of diabetes using Salacia oblonga extract
USRE38566E1 (en) Therapeutic carbohydrate blends for treating and aiding premenstrual syndrome
Fieldstone et al. Food preferences in Prader-Willi syndrome, normal weight and obese controls
Ladd et al. The effect of growth hormone supplementation on late nutritional independence in pediatric patients with short bowel syndrome
WO2007070454A2 (en) High protein supplement
Bray et al. Diet, weight loss, and cardiovascular disease prevention
McCutcheon et al. Hunger and appetitive factors during total parenteral nutrition
US8614184B2 (en) HCG formulations for achieving weight loss
US20150147298A1 (en) Sleep enhancement with cortisol reduction medical food
Caffry et al. Assessment of the effects of phenylpropanolamine on appetite and food intake
Bitarafan Effects of Bitter Substances on Energy Intake and Blood Glucose, and Associated Gastrointestinal Functions, in Healthy Humans
US8685918B1 (en) Weight loss regimen comprising enteral and oral feeding segments effective for the treatment of obesity
US20050250736A1 (en) Composition and method for treatment of obesity and smoking cessation